Rescheduling Delay Tests Patience of Cannabis Operators Like Green Thumb
Marijuana rescheduling was supposed to hand U.S. cannabis companies a measure of financial relief after years of waiting. Instead, a fresh procedural dispute is threatening to stretch out a review


